鋭科激光(300747.SZ):擬投資30億元建武漢鋭科光纖激光華中產業園項目
格隆匯6月8日丨鋭科激光(300747.SZ)公佈,公司擬與武漢未來科技城建設管理辦公室簽署投資協議,投資“武漢鋭科光纖激光華中產業園項目”,項目投資30億元,其中設備投資約15億元、包括基建在內的其它投資約15億元,主要生產包括連續光纖激光器、直接半導體激光器以及激光器核心上游元器件等。
此次投資主要用於建設特種光源研究與製造、工藝技術研究試驗、重點行業高端產品研發及製造、國家級檢測中心、技術人員培訓中心以及配套服務設施。通過本項目建設將提高公司的研發、智能製造、檢測、試驗能力,滿足公司“十四五”乃至中遠期發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.